ADRB3

(redirected from Beta-3 adrenoceptor)

ADRB3

A gene on chromosome 8p12 that encodes beta-1-adrenergic receptor, a member of the G protein-coupled receptor superfamily, which mediates catecholamine-induced activation of adenylate cyclase. ADRB3 is located primarily in adipose tissue and is involved in regulating lipolysis and thermogenesis.

References in periodicals archive ?

reviews for anti-muscarinic agents and beta-3 adrenoceptor agonist

CUA guideline on adult overactive bladder

Phase III contains three first-in-class molecules including beta-3 adrenoceptor agonists and cell therapy.

Research and Markets: The Global Urinary Incontinence (UI) Therapeutics Market is Expected to Reach $3.4 Billion by 2017 after Growing at a CAGR of 3.5%

Oral pharmacotherapies for the treatment of OAB include antimuscarinics such as solifenacin and the beta-3 adrenoceptor ([beta]3AR) agonist mirabegron.

Beta-3 adrenoceptor expression in the human urinary bladder nerve fibers.

What's new in functional urology research?

These include platelet acetylcholine blockers, Beta-3 adrenoceptor agonists, calcium influx inhibitors and intracellular calcium modulators and combinational therapies employing molecules which are Beta-3 adrenoceptor agonists, muscarinic receptor antagonists.

Research and Markets: Urinary Incontinence (UI) - Drug Pipeline Analysis and Market Forecasts Through to 2016